Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
Status:
Recruiting
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
A phase 2, randomized, open label, active comparator parallel controlled study to explore the
dosage regiment of rESP, and evaluate its efficacy, safety and pharmacokinetic
characteristics in the treatment of anemia in chronic renal failure patients with
hemodialysis